Ausgabe 3/2016
Inhalt (23 Artikel)
Peri-operative biology in primary breast cancer: a credible therapeutic target
Richard R. Love, Susan M. Love
Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions
Claire Johns, Susan M. Seav, Sally A. Dominick, Jessica R. Gorman, Hongying Li, Loki Natarajan, Jun James Mao, H. Irene Su
Neoadjuvant nab-paclitaxel in the treatment of breast cancer
Naoto T. Ueno, Eleftherios P. Mamounas
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
Lu Yao, Jie Sun, Juan Zhang, Yingjian He, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie
SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs
Karen Blyth, Phil Carter, Bethny Morrissey, Claude Chelala, Louise Jones, Ingunn Holen, Valerie Speirs
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer
Heather Greenlee, Katherine D. Crew, Jillian Capodice, Danielle Awad, Donna Buono, Zaixing Shi, Anne Jeffres, Sharon Wyse, Wendy Whitman, Meghna S. Trivedi, Kevin Kalinsky, Dawn L. Hershman
Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study
Lori M. van Roozendaal, Leonie H. M. Smit, Gaston H. N. M. Duijsens, Bart de Vries, Sabine Siesling, Marc B. I. Lobbes, Maaike de Boer, Johannes H. W. de Wilt, Marjolein L. Smidt
Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population
Seung Taek Lim, Jung Eun Choi, Sei Joong Kim, Hyun Ah Kim, Ji Young Kim, Heung Kyu Park, Young Jin Suh
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
Takayuki Iwamoto, Hiraku Kumamaru, Hiroaki Miyata, Ai Tomotaki, Naoki Niikura, Masaaki Kawai, Keisei Anan, Naoki Hayashi, Shinobu Masuda, Koichiro Tsugawa, Kenjiro Aogi, Takanori Ishida, Hideji Masuoka, Kotaro Iijima, Junji Matsuoka, Hiroyoshi Doihara, Takayuki Kinoshita, Seigo Nakamura, Yutaka Tokuda
Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens
Konrad Aumann, Kathrin Niermann, Jasmin Asberger, Ulrich Wellner, Peter Bronsert, Thalia Erbes, Dieter Hauschke, Elmar Stickeler, Gerald Gitsch, Gian Kayser, Martin Werner
Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up
G. Murtagh, T. Lyons, E. O’Connell, J. Ballot, L. Geraghty, D. Fennelly, G. Gullo, M. Ledwidge, J. Crown, J. Gallagher, C. Watson, K. M. McDonald, J. M. Walshe
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
Milagros González-Rivera, Miriam Lobo, Sara López-Tarruella, Yolanda Jerez, María del Monte-Millán, Tatiana Massarrah, Rocío Ramos-Medina, Inmaculada Ocaña, Antoni Picornell, Sonia Santillán Garzón, Lucía Pérez-Carbornero, José A. García-Saenz, Henry Gómez, Fernando Moreno, Iván Márquez-Rodas, Hugo Fuentes, Miguel Martin
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
L. M. van Roozendaal, B. Goorts, M. Klinkert, K. B. M. I. Keymeulen, B. De Vries, L. J. A. Strobbe, C. A. P. Wauters, Y. E. van Riet, E. Degreef, E. J. T. Rutgers, J. Wesseling, M. L. Smidt
High use of complementary and alternative medicine among a large cohort of women with a family history of breast cancer: the Sister Study
Heather Greenlee, Christine L. Sardo Molmenti, Laura Falci, Ross Ulmer, Sandra Deming-Halverson, Lisa A. DeRoo, Dale P. Sandler
Prognostic factors in male breast cancer: a population-based study
José Pablo Leone, Ariel Osvaldo Zwenger, Julián Iturbe, Julieta Leone, Bernardo Amadeo Leone, Carlos Teodoro Vallejo, Rohit Bhargava
Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy
Chalanda N. Evans, Noel T. Brewer, Susan T. Vadaparampil, Marc Boisvert, Yvonne Ottaviano, M. Catherine Lee, Claudine Isaacs, Marc D. Schwartz, Suzanne C. O’Neill
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Jan C. Drooger, Bernadette A. M. Heemskerk-Gerritsen, Nyrée Smallenbroek, Cynthia Epskamp, Caroline M. Seynaeve, Agnes Jager
Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls
Kathy Pan, Rowan T. Chlebowski, Michael S. Simon, Roberta M. Ray, Jennifer Livaudais-Toman, Shannon D. Sullivan, Marcia L. Stefanick, Robert B. Wallace, Meryl LeBoff, Elizabeth Carhart Bluhm, Electra D. Paskett
Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer
B. Cabarrou, L. Belin, S. M. Somda, M. C. Falcou, J. Y. Pierga, Y. Kirova, J. P. Delord, B. Asselain, T. Filleron
The incidence of bone metastasis after early-stage breast cancer in Canada
Alexander Liede, Katarzyna J. Jerzak, Rohini K. Hernandez, Sally W. Wade, Ping Sun, Steven A. Narod
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
Young-Ae Kim, Hee Jin Lee, Sun-Hee Heo, Hye Seon Park, Suk Young Park, WonSeon Bang, In Hye Song, In Ah Park, Gyungyub Gong
Erratum to: A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer
Sepideh Gholami, Andrew Marano, Nanhai G. Chen, Richard J. Aguilar, Alexa Frentzen, Chun-Hao Chen, Emil Lou, Sho Fujisawa, Clarisse Eveno, Laurence Belin, Pat Zanzonico, Aladar Szalay, Yuman Fong
Erratum to: FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
Juan Du, Lin Li, Zhouluo Ou, Chenfei Kong, Yu Zhang, Zhixiong Dong, Shan Zhu, Hao Jiang, Zhimin Shao, Baiqu Huang, Jun Lu